Project Details
Description
A Phase 1 Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of ACE-232 in Patients with Metastatic Castration-Resistant Prostate Cancer (CRPC)
| Status | Active |
|---|---|
| Effective start/end date | 2/17/25 → 2/16/36 |
Funding
- ACERAND THERAPEUTICS (USA) LIMITED
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.